Ipratropiumbromid/Salbutamol Neutec (Ipratropium Bromide, Salbutamol)

• Ipratropium bromide / Salbutamol is a combination bronchodilator used in the management of obstructive airway diseases.
• Asthma: provides rapid bronchodilation to relieve acute bronchospasm and improve airflow.
• Chronic obstructive pulmonary disease (COPD): enhances bronchodilation, reduces dyspnea and improves exercise tolerance.
• Exercise‑induced bronchoconstriction: may be used as a rescue inhaler to prevent symptoms during physical activity.
• Acute bronchospasm: offers quick relief of sudden airway narrowing in emergency situations.

• The formulation combines ipratropium bromide, a muscarinic receptor antagonist that blocks acetylcholine‑mediated bronchoconstriction, with salbutamol, a short‑acting β2‑adrenergic agonist that stimulates β2 receptors on airway smooth muscle, causing relaxation. The dual action produces additive bronchodilation, rapidly opening airways and improving ventilation in obstructive lung conditions. This synergistic effect helps to quickly relieve symptoms such as wheezing, coughing and shortness of breath.

Inhalation of Ipratropium bromide / Salbutamol may be associated with a range of adverse reactions.

Common Side Effects

• Throat irritation: mild soreness or discomfort in the throat.
• Cough: transient coughing after inhalation.
• Dry mouth: reduced salivary secretion.
• Tremor: mild shaking of hands or limbs.

Serious or Rare Side Effects

• Paradoxical bronchospasm: sudden worsening of breathing difficulty.
• Cardiac arrhythmias: rapid or irregular heartbeat, especially in patients with heart disease.
• Allergic reactions: rash, swelling, or anaphylaxis.

Before prescribing Ipratropium bromide / Salbutamol, clinicians should consider several safety measures.

• Cardiac history: assess for arrhythmias or ischemic heart disease.
• Blood pressure: monitor for hypertension, especially with salbutamol.
• Hypersensitivity: avoid in patients with known allergy to either component.
• Concurrent β‑blockers: may diminish bronchodilator effect.
• Pregnancy and lactation: use only if benefit outweighs risk.
• Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Ipratropium bromide / Salbutamol can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid)

• Non‑selective β‑blockers: may block salbutamol’s bronchodilatory action.
• Monoamine oxidase inhibitors (MAOIs): increase risk of cardiovascular side effects.

Moderate Interactions (Monitor Closely)

• Diuretics: may potentiate hypokalemia caused by salbutamol.
• Theophylline: increased risk of tachycardia and tremor.
• ACE inhibitors: may enhance cough or bronchospasm.